Literature DB >> 2232503

Defenses of an unstable compromise: crystallization inhibitors and the kidney's role in mineral regulation.

F Coe1, J H Parks.   

Abstract

Mesh：

Substances：

Year:  1990        PMID： 2232503     DOI： 10.1038/ki.1990.252

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  5 in total

1.  Inhibition of calcium oxalate crystal growth in vitro by uropontin: another member of the aspartic acid-rich protein superfamily.

Authors:  H Shiraga; W Min; W J VanDusen; M D Clayman; D Miner; C H Terrell; J R Sherbotie; J W Foreman; C Przysiecki; E G Neilson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

Review 2.  Do "inhibitors of crystallisation" play any role in the prevention of kidney stones? A critique.

Authors:  William G Robertson
Journal:  Urolithiasis       Date:  2016-11-29       Impact factor: 3.436

3.  Calcium phosphate: an important crystal phase in patients with recurrent calcium stone formation?

Authors:  H G Tiselius; L Larsson
Journal:  Urol Res       Date:  1993-05

Review 4.  Adverse renal and metabolic effects associated with oral sodium phosphate bowel preparation.

Authors:  Eliot C Heher; Samuel O Thier; Helmut Rennke; Benjamin D Humphreys
Journal:  Clin J Am Soc Nephrol       Date:  2008-07-02       Impact factor: 8.237

Review 5.  Causes and prevention of calcium-containing renal calculi.

Authors:  R A Sutton
Journal:  West J Med       Date:  1991-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.